SEC Comment Letter for AMYRIS, INC. (CIK 0001365916) — Jul 16, 2020
AMYRIS, INC. (CIK 0001365916)
Date: July 16, 2020 · CIK: 0001365916 · Accession: 0000000000-20-006517
AI Filing Summary & Sentiment
File numbers found in text: 333-239823
Letter
United States securities and exchange commission logo July 16, 2020 John Melo President and Chief Executive Officer Amyris, Inc. 5885 Hollis Street, Ste. 100 Emeryville, California 94608 Re:Amyris, Inc. Registration Statement on Form S-1 Filed July 10, 2020 File No. 333-239823 Dear Mr. Melo: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason L. Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Amanda L. Rose, Esq.
Show Raw Text
United States securities and exchange commission logo
July 16, 2020
John Melo
President and Chief Executive Officer
Amyris, Inc.
5885 Hollis Street, Ste. 100
Emeryville, California 94608
Re:Amyris, Inc.
Registration Statement on Form S-1
Filed July 10, 2020
File No. 333-239823
Dear Mr. Melo:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason L. Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Amanda L. Rose, Esq.